More than 15 abstracts showcase how the Veracyte Diagnostics Platform is advancing urologic cancer care with decisions guided by Decipher Prostate and Bladder tests SOUTH SAN FRANCISCO, ...
Profiling BCRAness phenotype in public prostate cancer datasets without homologous repair gene mutations. Cardiometabolic health’s influence on outcomes in men with localized high-risk prostate cancer ...
Good morning, everyone. I hope everyone's had a good week. Welcome to the 44th Annual JPMorgan Healthcare Conference. My name is Cliff, a member of the Healthcare Investment Banking team. And our next ...
A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results